Table 2.
Prevalence of Type-Specific HPV in Anal and Oral Specimens From Participating Transgender Women and Gay, Bisexual, and Other Men Who Have Sex With Men
| HPV Type | Anal and/or Oral HPV | Anal HPV | Oral HPV |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Any HPV types | |||
| ≥1 HPV type | 1253 (70.9) | 1236 (69.9) | 133 (7.5) |
| 4vHPV types | |||
| HPV 6 | 252 (14.3) | 244 (13.8) | 16 (0.9) |
| HPV 11 | 72 (4.1) | 71 (4.0) | 3 (0.2) |
| HPV 16 | 182 (10.3) | 177 (10.0) | 8 (0.5) |
| HPV 18 | 84 (4.8) | 83 (4.7) | 6 (0.3) |
| ≥1 4vHPV type | 475 (26.9) | 465 (26.3) | 33 (1.9) |
| All 4 | 0 (0) | 0 (0) | 0 (0) |
| Additional 9vHPV types not targeted by 4vHPV* | |||
| ≥1 additional 9vHPV type | 346 (19.6) | 342 (19.4) | 10 (0.6) |
| All 5 | 0 (0) | 0 (0) | 0 (0) |
| 9vHPV types | |||
| ≥1 9vHPV type | 669 (37.9) | 658 (37.2) | 40 (2.3) |
| All 9 | 0 (0) | 0 (0) | 0 (0) |
Abbreviations: HPV, human papillomavirus; 4vHPV, quadrivalent HPV vaccine; 9vHPV, nonavalent HPV vaccine.
*Additional 9vHPV types defined as HPV 31, 33, 45, 52, and/or 58.